News and Media

Fact Sheets

President and CEO John Ducker
Corporate Headquarters Lake Zurich, Illinois, USA
Number of Employees More than 1,800
Parent Company Fresenius Kabi USA, LLC is a company of Fresenius Kabi AG, headquartered in Bad Homburg, Germany.
APP Vision To be the leading U.S./Canadian injectable pharmaceutical company, delivering excellence in our products and services with dedicated and committed employees to meet our customers’ needs and help improve the health and care of patients.
APP Products Fresenius Kabi USA, LLC offers a single source for products ranging from the most frequently used to those products with specialized indications. The company markets more than 120 products in over 400 dosages and formulations. Fresenius Kabi USA, LLC products are used in every area of clinical care, ranging from:
  • Cardiac Care
  • Dialysis
  • Emergency
  • Intensive Care
  • OB/GYN
  • Operating Room
  • Oncology
  • Orthopedics
  • Pediatrics
  • Psychiatry
  • Radiology
Market Position Fresenius Kabi USA, LLC is the #2 generic injectable supplier in the United States, and is the only U.S. generic company with a dedicated cephalosporin injectable plant.*

* Source: IMS November 2008 (YTD November 2008). Total Market includes all delivery systems (e.g., vials, systems, etc.)
Manufacturing Facilities
  • Melrose Park, Illinois
  • Grand Island, New York
  • Raleigh, North Carolina
Fresenius Kabi USA, LLC has the ability to manufacture a comprehensive range of products at each site including sterile powder, aseptic liquid and terminal sterilization.
Science, Production and Technology Center Skokie, Illinois
Countries Where
Products are Sold		 United States and Canada